PA News | PD Community News

The Parkinson Alliance is pleased to provide you with the latest news in our effort to finance research to help find the cause and cure of Parkinson's. 

PA News


Participants Invited to Take Survey on Swallowing and Parkinson’s Disease

The 23rd Parkinson’s Unity Walk to Take Place on Saturday, April 22nd in New York City’s Central Park


Bucks County Roadrunner Club Thanksgiving Day Race – Calling All Runners and Volunteers!

Participants Invited to Take Survey on Social Support and Parkinson’s Disease

Join Athleta & The Parkinson Alliance as We Shop for a Cause!

The Parkinson Alliance Announces the Annual Carnegie Center 5K and Fun Run Will Take Place on Saturday, September 24, 2016, in Princeton, NJ

The 22nd Parkinson’s Unity Walk Raised More Than $1.4 Million for Parkinson’s Research

Join Us at the Kingston Fest 8-7-16

Key Opinion Leaders Gathered at the Mid-Atlantic Consensus Meeting to Discuss Deep Brain Stimulation for Parkinson’s Disease

7th Annual Princeton Dines Out for Parkinson’s Awareness

Like Muhammad Ali was, Greg Grace in a Race to Beat Parkinson

Muhammad Ali, Truly the "Greatest"


Tango For Parkinson

Survey Examines Patient Perceptions of Nutrition and Diet in Managing the Symptoms of Parkinson’s Disease

7th Annual Princeton Dines Out for Parkinson

The 22nd Parkinson’s Unity Walk to Take Place on Saturday, April 23rd in New York City’s Central Park

Participants Invited to Take Survey on Cognition and Parkinson’s Disease

PD Community News


Autoimmunity May Have Role in Parkinson

Balance and Movement Improved in Animal Model of Parkinson’s Disease

Low-fat Dairy Intake May Raise Parkinson

Tom Isaacs, President of The Cure Parkinson

Acorda Therapeutics to Present Update on Phase 3 Study of CVT-301 in Parkinson’s Patients

Biomarkers for Cognitive Impairment in Parkinson

New App Adjusts Brain Stimulators For Parkinson’s Patients


NeuroDerm to Ring the Nasdaq Stock Market Opening Bell and Participate in the Parkinson’s Unity Walk

Medtronic Brain Therapies Sponsors Parkinson’s Unity Walk

Acorda Announces Long-Term Safety Data for CVT-301

JFK Medical Center Offers Parkinson’s Disease Educational Seminar 4.5.17

FDA Approves Xadago to Treat Parkinson’s Disease

Cancer Drug That Might Slow Parkinson

Study Shows Link Between Microbiome in the Gut and Parkinson

Researchers Suggest New Theory for How Parkinson

Researchers Discover Genetic Switch for Parkinson’s Disease

US WorldMeds is Funding Clinical Trial Studying Effectiveness of New Infusion Therapy to Help Smooth Out Movement for Patients with PD

Blood Test Might Make Parkinson

Acorda Announces Positive Phase 3 Clinical Trial Results for CVT-301

PWR! Parkinson’s Wellness Recovery Classes Being Offered in Princeton, NJ

Tell Congress How You May Be Impacted by Health Care Policy Changes

LSVT BIG Seminar on Sunday, February 5, 2017 in West Orange, NJ

CurePSP 2017 Southwest Family Conference to be Held in Phoenix on March 17-18, 2017

Adamas Announces US FDA Acceptance of ADS-5102 New Drug Application for the Treatment of Levodopa-induced Dyskinesia in Patients with PD

Single Protein May Hold Secret to Treating Parkinson’s Disease


Adjunctive Safinamide Increases On Time in Parkinson

Blocking Brain Enzyme Corrects Motor Symptoms in Mice

The 21st Century Cures Act is Signed into Law

Fat-coated Microbubbles May Aid Parkinson’s Treatment by Getting Past Blood Brain Barrier

Upright Posture in Patients with Parkinson’s Disease Exacerbates Cognitive Defecits

Parkinson’s Disease May Be Traced to Gut Bacteria

Janet Reno, Former Attorney General, Dies at 78 from Complications of PD

Michigan State University and Van Andel Research Institute Collaborate on Research to Slow the Progression of PD

Statin Use May Lead to Increased Risk for Parkinson’s Disease


More Research Needed for Using Skin Biopsies to Diagnose Parkinson’s Disease

New Drug Candidate May Reduce Deficits in Parkinson’s Disease

Adamas Pharma Announces Submission of ADS-5102 NDA to US FDA as Dyskinesia Treatment in PD Patients

GLNT and UCB Partner to Create Ways to Better Judge Effectiveness of Parkinson’s Treatment

Acorda Launches “The Many Faces of Off” Facebook Page to Support the Parkinson’s Community

Acorda’s CVT-301 for Parkinson’s ‘Off’ Periods Shows Promising Results in Preclinical Studies

New Device Helps Boost Movement in Parkinson

Experimental Immunotherapy May Slow Parkinson’s Disease Progression

Nest Planning Board: Coordinating Center to Prioritize Cooperative Projects

Global Kinetics Secures FDA Clearance to Market Upgraded Wearable for PD Patients

Diabetes Drug Focus of New Clinical Trial for Parkinson

Cynapsus Therapeutics Parkinson’s Disease Candidate Gets FDA Fast Track Designation

New Test May Help Detect Parkinson’s Disease in Early Stages of Life

Simple Eye Test May Detect Parkinson’s Disease

Manufacturing Dopamine in the Brain with Gene Therapy

NeuroDerm Initiates Patient Enrollment in a Phase III Trial of ND0612L for the Treatment of PD

Researchers Examine How Parkinson’s Disease Alters Brain Activity Over Time

Leukemia Drug Proven Effective Against Parkinson’s Disease

Cynapsus Announces Publication of Data for the Treatment of OFF Episodes in Patients with PD

Parkinson’s: Mutant Enzyme, a-Synuclein Interaction May Be Preventable

Local Dance for Parkinson’s Program Starting this Fall

The Michael J. Fox Foundation Expands Fox Trial Finder to Accelerate Research in Atypical Parkinsonism

Study Shows Cancer Drug Raises Dopamine Levels in Parkinson’s Patients


Johns Hopkins Researchers Reveal Novel Protein and Involvement in Parkinson’s Disease

Scientists Offer New View on Origins of Parkinson

NeuroDerm Presents Three Posters at the 20th International Congress of Parkinson’s Disease and Movement Disorders

MS Drug Could Prove Effective Parkinson

UCLA Scientists Discover Protective Strategy Against Pesticide-linked Parkinson’s Disease

New Gene Shown to Cause Parkinson

Great Lakes Neurotech Validation Studies on Wearable Tech for Parkinson’s to be Highlighted at International Conference

NeuroDerm Announces Patient Enrollment in Long-Term Safety Trial of ND0612 for PD

Senior Helpers Introduces First Ever In-Home Parkinson

U.S. Approves First drug for Psychosis Linked to Parkinson

Adamas Pharma (ADMS) Announces ADS-5102 Phase 3 Met Primary, Key Secondary Endpoints as LID Treatment

Common Gene Variation May Predict Parkinson’s Severity and Progression

Blood Test to Detect Parkinson

New England and Canada Parkinson’s Cruise

Cynapsus Therapeutics’ APL-130277 Phase III Study Focus of Presentation

Acorda Therapeutics’ CVT-301 Data Will Be Featured at American Academy of Neurology

Pfizer and IBM Launch Innovative Research Project to Transform Parkinson

Michael J. Fox Foundation for Parkinson’s Research and Parkinson’s Action Network Announce Plans for Integration

The Parkinson Alliance (Responsible for the Parkinson’s Unity Walk, Team Parkinson, and Joins Unified Parkinson’s Advocacy Council

U.S. WorldMeds and Zambon Partner to Bring Newron Pharmaceuticals’ Parkinson’s Disease Treatment Xadago to the U.S.

Titan Pharmaceuticals Receives Feedback from FDA on Ropinirole Implant Development Program for PD

Parkinson’s Disease Drug Xadago Now Available in Italy as Add-On Therapy to Levodopa

Neurolixis Announces Publications Demonstrating Effects of NLX-112 in Parkinson

Respiratory Drug Focus of New Clinical Trial for Parkinson’s Disease

New Gene Therapy Clinical Trial

Researchers Identify Biomarker for Early Cognitive Decline in Parkinson

Mitochondrial DNA Levels in the Blood Help to Detect Onset of Parkinson’s Disease

Study Determines Saliva Gland Test Can Spot Early Parkinson

APDA Establishes Research Fund in Memory of Joel Gerstel

Acorda Therapeutics to Acquire Biotie Therapies

New Jersey Health Foundation/The Nicholson Foundation Award $50,000 to Advance Research to Slow Brain Degeneration in Parkinson

Dementia Drug May Improve Gait in Parkinson

Dementia Drug May Improve Gait in Parkinson


Back to top